Anika Therapeutics (ANIK) (fka )

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

BioSpecialist Free

03/16/11 9:06 AM

Post #39

Great buying opp

BioSpecialist Free

03/15/11 2:49 PM

Post #38

Another breakout is imminent

Still ver very cheap

BioSpecialist Free

03/15/11 8:34 AM

Post #37

Time to load up before the next jump coming

BioSpecialist Free

03/14/11 8:28 AM

Post #36

Anik is still one of the best and undervalued Bio stocks out there .Still a huge buying opportunity . glta

BioSpecialist Free

03/11/11 12:06 PM

Post #35

RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY

Load up the truck before it moves over 20$ . Anik awaiting 6 Approvals ENUFF said .

BioSpecialist Free

03/11/11 8:29 AM

Post #34

Major Breakout on the way

BioSpecialist Free

03/10/11 1:49 PM

Post #33

DOUBLE DIGITS TODAY WOOOP

BioSpecialist Free

03/10/11 12:23 PM

Post #32

RALLLYYYYYYYYYYYYYYYYYYYYYYYYY

Load up before its too late ..Easy mony from here .GL

BioSpecialist Free

03/10/11 7:27 AM

Post #31

Anik is a big buying opportunity . Load up on the cheap while you still can . GL

There is really a lot of good news coming ..Anik will explode today !

Great Fourth Quarter Results
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzc0MzM4M3xDaGlsZElEPTQxNzQyMXxUeXBlPTI=&t=1

BioSpecialist Free

03/09/11 7:21 PM

Post #30

ANIK exploding after hour

Great results out .. Still a huge opportunity .GL

BioSpecialist Free

03/09/11 3:16 PM

Post #29

Still a huge buying opportunity ..

5 Approvals pending

BioSpecialist Free

03/08/11 1:14 PM

Post #28

Last chance to load up below 9$

BioSpecialist Free

03/07/11 2:39 PM

Post #27

GREAT BUYING OPPORTUNITY TODAY

LOAD UP WHILE ITS VERY CHEAP

BioSpecialist Free

03/07/11 8:45 AM

Post #26

Major Rally coming if we break 10$

2011 Price Target: $30.00+

UPCOMING MILESTONES :

Monovisc (osteoarthritis) (PMA) FDA approval in 1Q or early 2Q 2011 << Blockbuster Potential

Hyaloglide 510(K) expected FDA approval 1Q or early 2Q 2011

Hyalonect 510(K) expected FDA approval 1Q or early 2Q 2011

Hyalofast 510(K) expected FDA approval 1Q or early 2Q 2011

FAB has commercialized three joint health products that Anika is planning to market in the United States along with MONOVISC™, upon its approval by the FDA. These FAB products include:

* Hyaloglide®, a gel used following tendon and/or peripheral nerve surgery;

* Hyalonect®, a knitted mesh used as a bone graft wrap; and

* Hyalofast™, a non woven matrix of HA used in arthroscopic surgery for the repair of chondral and osteochondral lesions.

We believe these products will only require FDA 510K clearance. These three products – as well as most others in FAB’s portfolio – come with a meaningful clinical data package.

Our goal is to obtain FDA clearance for Hyaloglide, Hyalonect and Hyalofast by the end of Q1 2011. We are building a direct sales force to market MONOVISC in the United States, and adding these three products to our portfolio should provide us with the critical mass we need to more effectively penetrate the domestic orthopedic/joint health market.

gofrbrokenow Free

03/05/11 6:46 PM

Post #25

Re: #24: @BioSpecialist - Breakout coming

what do you see this going to

BioSpecialist Free

03/04/11 8:42 AM

Post #24

Breakout coming

BioSpecialist Free

03/03/11 11:06 AM

Post #23

Anik will explode if we break 10$ today

Still a huge buying opportunity .

BioSpecialist Free

03/02/11 7:39 AM

Post #22

Re: #1: @BioSpecialist - 4 FDA approvals this Q(Mcap 96 M) Hot

Anik is on the move ...

Major Rally coming if we break $10 today .Still a fantastic buying opportunity .

BioSpecialist Free

03/01/11 3:01 PM

Post #21

Runup started

5 Approvals coming soon

BioSpecialist Free

02/25/11 1:03 PM

Post #20

Still time to get in on the cheap .

BioSpecialist Free

02/25/11 7:40 AM

Post #19

The Institutions increased their stake in Anika from 30% to 51% in the last few days .VERY POSITIVE SIGN

http://www.dailyfinance.com/company/anika-therapeutics-inc/anik/nas/institutional-ownership

Shares Outstanding: 13.4 M

Insiders/Mutual/Institutions holding : 8.4 M

Float : 5 M (excluding retail investors)

BioSpecialist Free

02/23/11 2:08 PM

Post #18

This is the perfect buying time

Big News is around the corner

BioSpecialist Free

02/22/11 10:39 AM

Post #17

Good day to load up more cheap shares .

BioSpecialist Free

02/18/11 11:26 AM

Post #16

RALLLYYYYYYYYYYYYYYYYYYYYYYY

10$++++ coming yipppiiii

BioSpecialist Free

02/17/11 10:27 AM

Post #15

Last chance to get in below 9$ .

Anika Therapeutics (ANIK)

Market-Cap: 116 Mil
Cash: 26 Mil
Price: 8.60

Shares Out: 13.5

UPCOMING MILESTONES :

Monovisc (osteoarthritis) (PMA) FDA approval in 1Q 2011 << Blockbuster Potential

Hyaloglide 510(K) expected FDA approval 1Q 2011

Hyalonect 510(K) expected FDA approval 1Q 2011

Hyalofast 510(K) expected FDA approval 1Q 2011

FAB has commercialized three joint health products that Anika is planning to market in the United States along with MONOVISC™, upon its approval by the FDA. These FAB products include:

* Hyaloglide®, a gel used following tendon and/or peripheral nerve surgery;

* Hyalonect®, a knitted mesh used as a bone graft wrap; and

* Hyalofast™, a non woven matrix of HA used in arthroscopic surgery for the repair of chondral and osteochondral lesions.

We believe these products will only require FDA 510K clearance. These three products – as well as most others in FAB’s portfolio – come with a meaningful clinical data package.

Our goal is to obtain FDA clearance for Hyaloglide, Hyalonect and Hyalofast by the end of Q1 2011. We are building a direct sales force to market MONOVISC in the United States, and adding these three products to our portfolio should provide us with the critical mass we need to more effectively penetrate the domestic orthopedic/joint health market.

gofrbrokenow Free

02/16/11 11:03 PM

Post #14

great call on this on biospecialist

BioSpecialist Free

02/16/11 10:19 AM

Post #13

What a bargain

BioSpecialist Free

02/15/11 12:44 PM

Post #12

GREAT BUYING OPPORTUNITY TODAY FOLKS

4 FDA APPROVALS COMING VERY SOON = EASY $$$$

BioSpecialist Free

02/14/11 11:22 AM

Post #11

Load up before the first FDA approval coming ....

Anika Therapeutics (ANIK)

Market-Cap: 116 Mil
Cash: 26 Mil
Price: 8.60

Shares Out: 13.5

UPCOMING MILESTONES :

Monovisc (osteoarthritis) (PMA) FDA approval in 1Q 2011 << Blockbuster Potential

Hyaloglide 510(K) expected FDA approval 1Q 2011

Hyalonect 510(K) expected FDA approval 1Q 2011

Hyalofast 510(K) expected FDA approval 1Q 2011

FAB has commercialized three joint health products that Anika is planning to market in the United States along with MONOVISC™, upon its approval by the FDA. These FAB products include:

* Hyaloglide®, a gel used following tendon and/or peripheral nerve surgery;

* Hyalonect®, a knitted mesh used as a bone graft wrap; and

* Hyalofast™, a non woven matrix of HA used in arthroscopic surgery for the repair of chondral and osteochondral lesions.

We believe these products will only require FDA 510K clearance. These three products – as well as most others in FAB’s portfolio – come with a meaningful clinical data package.

Our goal is to obtain FDA clearance for Hyaloglide, Hyalonect and Hyalofast by the end of Q1 2011. We are building a direct sales force to market MONOVISC in the United States, and adding these three products to our portfolio should provide us with the critical mass we need to more effectively penetrate the domestic orthopedic/joint health market.

BioSpecialist Free

02/11/11 11:40 AM

Post #10

pull back is a great buying opportunity .

4 FDA approvals coming to push this stock to ath

BioSpecialist Free

02/10/11 10:12 AM

Post #9

If we break 10$ today then it will run to 15$ quickly .

BioSpecialist Free

02/09/11 3:30 PM

Post #8

Load up folks

Major Breakout coming ..

BioSpecialist Free

02/09/11 11:14 AM

Post #7

RALLYYYYYYYYYYYYYYYYYYYYYYY

Last chance to load up below 10$ .

4 FDA APPROVALS COMING TO PUSH THIS STOCK TO 30$ ..

BioSpecialist Free

02/08/11 11:42 AM

Post #6

Nice consolidation

Rally will continue very soon ..

BioSpecialist Free

02/07/11 12:06 PM

Post #5

Great buying opportunity today ..Load up before the big News is out .

BioSpecialist Free

02/07/11 4:21 AM

Post #4

This stock is still significantly Undervalued . Anik awaiting 4 FDA approvals including one potential Blockbuster(Monovisc) , the first Approval could push this stock to $15+ .I think we could see $30+ with all FDA approvals . Anika is definitely one of the best Biotech Investment .GL

http://stockcharts.com/freecharts/gallery.html?anik

BioSpecialist Free

02/04/11 7:26 AM

Post #3

Load up before the stock moves into double digits .Anything below 12$ is a pure gift . GL

http://www.stoxline.com/quote.php?symbol=anik

Resistance1: 9.78
Resistance2: 11.42

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

jayree

02/03/11 9:08 AM

Post #2

will pick this up today... thanks !

BioSpecialist Free

02/03/11 6:34 AM

Post #1

4 FDA approvals this Q(Mcap 96 M) Hot Pick 2011

With a market value of $96 million, Anika Therapeutics (ANIK) is a hidden growth story in the biotech arena .ANIK has been profitable for each of the past seven years.

2011 Price Target: $25.00+ .Get in now before the stock gets Discovered .Buy with both hands now and you will make a lot of money with the upcoming FDA approvals .Anika is a once in a lifetime opportunity .GLTA

Anika Therapeutics (ANIK)

Market-Cap: 96 Mil
Cash: 26 Mil
Price: 7.20

Shares Out: 13.5

UPCOMING MILESTONES :

Monovisc (osteoarthritis) (PMA) FDA approval in 1Q 2011 << Blockbuster Potential

Hyaloglide 510(K) expected FDA approval 1Q 2011

Hyalonect 510(K) expected FDA approval 1Q 2011

Hyalofast 510(K) expected FDA approval 1Q 2011

Big Pipeline
http://www.anikatherapeutics.com/innovation/pipeline/index.html

Insider Ownership
http://www.dailyfinance.com/company/anika-therapeutics-inc/anik/nas/institutional-ownership

http://www.anikatherapeutics.com/innovation/spotlight/index.html

FAB has commercialized three joint health products that Anika is planning to market in the United States along with MONOVISC™, upon its approval by the FDA. These FAB products include:

* Hyaloglide®, a gel used following tendon and/or peripheral nerve surgery;

* Hyalonect®, a knitted mesh used as a bone graft wrap; and

* Hyalofast™, a non woven matrix of HA used in arthroscopic surgery for the repair of chondral and osteochondral lesions.

We believe these products will only require FDA 510K clearance. These three products – as well as most others in FAB’s portfolio – come with a meaningful clinical data package.

Our goal is to obtain FDA clearance for Hyaloglide, Hyalonect and Hyalofast by the end of Q1 2011. We are building a direct sales force to market MONOVISC in the United States, and adding these three products to our portfolio should provide us with the critical mass we need to more effectively penetrate the domestic orthopedic/joint health market.

Anika Therapeutics (ANIK) (fka )

Followers	2	Posters	3
Posts (Today)	0	Posts (Total)	39
Created	02/03/11	Type	Free
Moderators

4 FDA approvals this Q(Mcap 96 M) Hot Pick 2011 With a market value of $96 million, Anika Therapeutics (ANIK) is a hidden growth story in the biotech arena .ANIK has been profitable for each of the past seven years. 2011 Price Target: $25.00+ .Get in now before the stock gets Discovered .Buy with both hands now and you will make a lot of money with the upcoming FDA approvals .Anika is a once in a lifetime opportunity .GLTA Anika Therapeutics (ANIK) Market-Cap: 96 Mil Cash: 26 Mil Price: 7.20 Shares Out: 13.5 UPCOMING MILESTONES : Monovisc (osteoarthritis) (PMA) FDA approval in 1Q 2011 << Blockbuster Potential Hyaloglide 510(K) expected FDA approval 1Q 2011 Hyalonect 510(K) expected FDA approval 1Q 2011 Hyalofast 510(K) expected FDA approval 1Q 2011 Big Pipeline http://www.anikatherapeutics.com/innovation/pipeline/index.html Insider Ownership http://www.dailyfinance.com/company/anika-therapeutics-inc/anik/nas/institutional-ownership http://www.anikatherapeutics.com/innovation/spotlight/index.html FAB has commercialized three joint health products that Anika is planning to market in the United States along with MONOVISC™, upon its approval by the FDA. These FAB products include: * Hyaloglide®, a gel used following tendon and/or peripheral nerve surgery; * Hyalonect®, a knitted mesh used as a bone graft wrap; and * Hyalofast™, a non woven matrix of HA used in arthroscopic surgery for the repair of chondral and osteochondral lesions. We believe these products will only require FDA 510K clearance. These three products – as well as most others in FAB’s portfolio – come with a meaningful clinical data package. Our goal is to obtain FDA clearance for Hyaloglide, Hyalonect and Hyalofast by the end of Q1 2011. We are building a direct sales force to market MONOVISC in the United States, and adding these three products to our portfolio should provide us with the critical mass we need to more effectively penetrate the domestic orthopedic/joint health market.

Board Info

Posts Today	0
Posts (Total)	39
Posters	3
Moderators

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Anika Therapeutics (ANIK) (fka )

Anika Therapeutics (ANIK) (fka )

Join the InvestorsHub Community

Anika Therapeutics (ANIK) (fka )

Board Info